Series A · Biotech
Stellular Bio: Series A
Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases
Funding history
Series A · This roundUndisclosed
Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases